Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Mon - Fri: 8:00 am - 7:00 pm
Saturday: 9:00 am - 7:00 pm
Sunday: 9:00 am - 7:00 pm
+66 98-828-1773
[email protected]

Gallery Posts

Author: admin

Ototoxicity (OTX) refers to damage to the inner ear caused by certain medications or chemicals, leading to hearing loss, tinnitus, or balance problems. This condition affects the cochlea and vestibular system, which are responsible for hearing and balance, respectively. Below is a detailed overview of ototoxicity, including its causes, symptoms, diagnosis, and management strategies.
64 Views0 Comments

Ototoxicity (OTX)

Ototoxicity (OTX) refers to damage to the inner ear caused by certain medications or chemicals, leading to hearing loss, tinnitus, or balance problems. This condition affects the cochlea and vestibular system,

Read More
Age-Related Cochlear Degeneration (ARCD), commonly referred to as presbycusis or age-related hearing loss (ARHL), is a progressive sensorineural hearing impairment caused by degenerative changes in the cochlea and auditory pathways. It is one of the most prevalent chronic conditions in older adults, significantly affecting communication, quality of life, and cognitive health. Below is a detailed summary of ARCD, its mechanisms, symptoms, and management.
65 Views0 Comments

Age-Related Cochlear Degeneration (ARCD)

Age-Related Cochlear Degeneration (ARCD), commonly referred to as presbycusis or age-related hearing loss (ARHL), is a progressive sensorineural hearing impairment caused by degenerative changes in the cochlea and auditory pathways. It

Read More
Noise-Induced Hearing Loss (NIHL) is a sensorineural hearing impairment caused by exposure to loud sounds that damage the delicate hair cells in the inner ear. It is a preventable yet irreversible condition that affects individuals of all ages. Below is a detailed overview of NIHL, including its causes, symptoms, diagnosis, and prevention strategies.
106 Views0 Comments

Noise-Induced Hearing Loss (NIHL)

Noise-Induced Hearing Loss (NIHL) is a sensorineural hearing impairment caused by exposure to loud sounds that damage the delicate hair cells in the inner ear. It is a preventable yet irreversible

Read More
Constitutional symptoms (CS) refer to systemic changes that affect the overall health and well-being of an individual. In the context of lung cancer, these symptoms often manifest as the disease progresses and can include unexplained weight loss, fatigue, malaise, and fever. Below is a detailed overview of constitutional symptoms associated with lung cancer.
91 Views0 Comments

Constitutional Symptoms (CS)

Constitutional symptoms (CS) refer to systemic changes that affect the overall health and well-being of an individual. In the context of lung cancer, these symptoms often manifest as the disease progresses

Read More
Pancoast tumors (PCT) are a rare type of lung cancer located at the apex of the lung, typically involving the superior sulcus. They are characterized by their aggressive nature and invasion into nearby structures, leading to distinctive symptoms known as Pancoast syndrome. Below is a detailed overview of Pancoast tumors, including their symptoms, diagnosis, and treatment options.
67 Views0 Comments

Pancoast Tumors (PCT)

Pancoast tumors (PCT) are a rare type of lung cancer located at the apex of the lung, typically involving the superior sulcus. They are characterized by their aggressive nature and invasion

Read More
Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking specific features of other NSCLC subtypes like adenocarcinoma or squamous cell carcinoma. Below is a detailed overview of LCC, including its symptoms, diagnosis, and treatment options.
95 Views0 Comments

Large Cell Carcinoma (LCC)

Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking

Read More
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer (SCLC) but is often diagnosed at advanced stages due to its asymptomatic early course. Below is a detailed overview of NSCLC, including its subtypes, symptoms, risk factors, and treatment approaches.
119 Views0 Comments

Non-Small Cell Lung Cancer (NSCLC)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer

Read More
Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes, TKIs disrupt abnormal signaling in diseases like cancer and inflammatory disorders. Below is a detailed overview of TKIs, including their mechanisms, therapeutic uses, and challenges.
66 Views0 Comments

Tyrosine Kinase Inhibitors (TKI)

Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes,

Read More
Circulating tumor DNA (ctDNA) refers to DNA fragments released into the bloodstream by cancer cells. These fragments can originate from tumor cells undergoing apoptosis, necrosis, or active release. ctDNA is a valuable tool in cancer diagnosis, treatment monitoring, and personalized medicine due to its ability to reflect the genetic makeup of tumors. Below is a detailed overview of ctDNA, including its mechanisms, clinical applications, and challenges.
114 Views0 Comments

Circulating Tumor DNA (CTDNA)

Circulating tumor DNA (ctDNA) refers to DNA fragments released into the bloodstream by cancer cells. These fragments can originate from tumor cells undergoing apoptosis, necrosis, or active release. ctDNA is a

Read More
126 Views0 Comments

Nanoparticle-Assisted Tumor Tracking (NATT)

Nanoparticle-Assisted Tumor Tracking (NATT) is an advanced approach in cancer research and treatment that uses nanoparticles to detect, monitor, and target tumors. This technology leverages the unique physicochemical properties of nanoparticles

Read More

Gallery Posts

gal 1 1
gal 1 2
gal 1 3
gal 1 4
gal 1 5
gal 1 6

Copyright 2025 DrStemCellsThailand. All Rights Reserved by Anti-Aging and Regenerative Medicine Center of Thailand